Patents by Inventor Douglas FRASER-PITT

Douglas FRASER-PITT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-VIRAL THERAPY
    Publication number: 20230338310
    Abstract: The invention relates to the use of compounds, and compositions comprising such compounds, for treating viral infection. More specifically, the compounds for use in the invention are comprised of structural formula (1), or a pharmaceutically acceptable salt thereof. The invention also relates to the compounds for use in treating hyperinflammation.
    Type: Application
    Filed: May 25, 2021
    Publication date: October 26, 2023
    Inventors: Deborah O'NEIL, Douglas FRASER-PITT
  • Cysteamine as Neutrophil Elastase Inhibitor
    Publication number: 20180344671
    Abstract: The present invention relates to compositions of cysteamine or a derivative thereof for use in the treatment or prophylaxis or a disease or condition associated with neutrophil elastase activity. The compositions can be administered, e.g., by inhalation, intravenously, or topically, as appropriate.
    Type: Application
    Filed: June 4, 2018
    Publication date: December 6, 2018
    Inventors: Deborah O'Neil, Douglas Fraser-Pitt
  • An Amino Thiol for Use in the Treatment of an Infection Caused by the Bacterium Mycobacterium Spp
    Publication number: 20180185305
    Abstract: The present invention relates to cysteamine, cystamine, or derivatives thereof, for use in the treatment and/or prevention of infection caused by the bacterium, Mycobacterium spp., in particular Mycobacterium abscessus, or a disease or condition associated therewith.
    Type: Application
    Filed: June 6, 2016
    Publication date: July 5, 2018
    Inventors: Deborah O'NEIL, Douglas FRASER-PITT
  • Treatment of Drug-Resistant Microbial Infections
    Publication number: 20170348253
    Abstract: The present invention provides a sulphur-containing compound for use in the prophylaxis or treatment of an infection associated with at least one microbe or microbial strain displaying at least some degree of drug resistance. Also provided is a product comprising a first agent being a sulphur-containing compound and a second agent being an antimicrobial agent, in particular an antibiotic agent.
    Type: Application
    Filed: June 6, 2017
    Publication date: December 7, 2017
    Inventors: Deborah O'NEIL, Douglas FRASER-PITT